Patent ID: 8901110
Filing Date: 2014-12-02
Classification: C12Q,G01N

Abstract:
1. A method of treating hepatocellular carcinoma, comprising: identifying a subject having hepatocellular carcinoma who is likely to be responsive to a treatment compound, comprising: and administering a therapeutically effective amount of the treatment compound to the subject identified to be likely to be responsive to the treatment; wherein the hepatocellular carcinoma is poorly differentiated hepatocellular carcinoma; and wherein the treatment compound is thalidomide, lenalidomide, pomalidomide, or 3-(5-amino-2-methyl-4-oxo-4H-quinazolin-3-yl)-piperidine-2,6-dione, or a stereoisomer thereof, or a pharmaceutically acceptable salt, solvate, hydrate, co-crystal, clathrate, or a polymorph thereof.